Finding a liability-free space in which personalized medicine can bloom

被引:7
作者
Evans, B. J. [1 ]
机构
[1] Univ Houston, Ctr Law, Hlth Law & Policy Inst, Houston, TX 77004 USA
[2] Univ Houston, Ctr Law, Ctr Biotechnol & Law, Houston, TX 77004 USA
[3] Indiana Univ, Sch Med, Div Clin Pharmacol, Indianapolis, IN 46204 USA
关键词
D O I
10.1038/sj.clpt.6100335
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Personalized medicine uses genetic and other screening tests to predict a patient's response to specific drug and biologic therapies ( together "drugs''), with the aim of choosing a treatment that will provide benefits while avoiding drug-related harms. There are two schools of thought on how tort liability may affect personalized medicine, i. e., whether fear of lawsuits will tend to accelerate progress or slow it down. Tort suits include product liability suits against manufacturers and negligence suits against physicians and other providers of health-related services.
引用
收藏
页码:461 / 465
页数:5
相关论文
共 32 条
[1]  
[Anonymous], INC POV HLTH INS COV
[2]  
BENSSHAHAR O, 2005, LIABILITY DISTORTS I
[3]  
BORZI PC, 2005, ERISA HLTH PLANS KEY
[4]   INCIDENCE OF ADVERSE EVENTS AND NEGLIGENCE IN HOSPITALIZED-PATIENTS - RESULTS OF THE HARVARD MEDICAL-PRACTICE STUDY-I [J].
BRENNAN, TA ;
LEAPE, LL ;
LAIRD, NM ;
HEBERT, L ;
LOCALIO, AR ;
LAWTHERS, AG ;
NEWHOUSE, JP ;
WEILER, PC ;
HIATT, HH .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (06) :370-376
[5]  
BRODY H, 2007, HOOKED ETHICS MED PR, P189
[6]  
Calabro Sheryl, 2004, CARDOZO L REV, V25, P2241
[7]   Ethical, legal, and social implications of genomic medicine [J].
Clayton, EW .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (06) :562-569
[8]  
CURRAN WJ, 1998, HLTH CARE LAW ETHICS, P314
[10]  
*EMP BEN RS I, 2006, FACTS EBRI TYP HLTH